Abstract
Transplantation is considered by the general public to be a spectacular achievement of modern medicine. Transplantation can be seen as a representation of the power of medicine to prolong life. Nature appears defeated if parts of the body which no longer function properly can be replaced. The idea that substitute organs are derived from the remains of a person who has lost his/her life may increase the perception of transplantation as a victory over death. Mankind recreates itself by performing transplants. The capacity of the human body to reject tissue from outside the body is controlled. The implanted organ, which is normally attacked by the immunosuppressive system, survives because the destructive and deadly process of rejection is disrupted by immunosuppressive agents. There is then a second victory over death when organ failure is prohibited and the implanted organ is permitted to survive, enabling the transplanted patient to live.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Drummond MF, Stoddard GL, Torrance GW. Methods for the Economie Evaluation of Health Care Programmes. Oxford University Press, Oxford 1987.
Mishan EJ. Cost-benefit analysis. Unwin Hyman, London.
De Charro FT, Kosten-effectiviteitsanalyse van het nierfunk-tievervangings-programma in Nederland. Eburon, Delft 1988.
Van Hout BA, Bonsei G, Habbema D, Van der Maas P, De Charro F. Heart transplantation in the Netherlands; costs, effects and scénarios. J Health Econ 1993; 12: 73–94.
Bonsei GJ, Essink-Bot ML, De Charro FT, Van der Maas PJ, Habbema JDF. Orthotopic liver transplantation in the Netherlands. The results and impact of a médical technology assessment. Health Policy 1990; 16: 147–62.
Dutch End Stage Renal Disease Registry, Renine: Annual Report. Rotterdam 1995.
Health Council. Report on Dialysis and Kidney Transplantation. Report 1986/9. The Hague 1986.
Hilbrands LB. Immunosuppressive drug therapy after renal transplantation: balancing the benefits and risks. PhD Thesis, Catholic University of Nijmegen 1996.
Evans RW, Manninen DL, Garrison LP et al.The quality of life of patients with end stage renal disease. New Engl J Med 1985; 312: 553–9.
de Wit A, Merkus M, de Charro F. Measuring utilities in an end stage renal disease population. In: Badia X, Herdman M, Segura A (eds), Discussion papers of the Plenary Meeting of EuroQol 1995. Catalan Institute of Public Health, Barcelona 1996.
Hart LG, Evans RW. The functional status of ESRD patients as measured by the Sickness Impact Profile. J Chronic Dis 1987; 40 (Suppl 1): 1175–130S.
Williams A. Economies of coronary artery bypass grafting. Br MedJ 1985; 291: 326–9.
Evans RW, Manninen DL, Overcast TD et al.The national heart transplantation study; final report. Battelle Human Affairs Research Centres, Seattle 1984.
Buxton MR, Acheson R, Caine N. Costs and benefits of the heart transplantation programmes at Harefield,md Papworth hospitals. DHSS Research Report No. 12. HMSO, London 1985.
Van Hout BA, Bonsei G, Habbema D, Van der Maas P, de Charro F. Heart transplantation in the Nethei lands; costs, effects and scénarios. J Health Econ 1993; 12: 73–94.
Bonsei GJ., Van Hout BA et al.Utility measurerient of health states by the général public using computer a>sisted inter-viewing. In: Bonsei GJ (ed.), Methods of Médical Technology Assessment with an Application to Liver Transplantation. Eburon, Delft 1991.
Pugh RNH, Marray-Lyon IM, Dawson JL et al.Transection of Oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646–9.
Bonsei GJ, Klompmaker IJ, Van ‘t Veer F, Hcbbema JDF, Slooff MJH. Use of prognostic models for assessment of value of liver transplantation in primary biliary cirrhosis. Lancet 1990; 335: 493–7.
Michel BC, Bonsei GJ, Stouthard MEA, Essink-Bot ML, McDonnell J, Habbema D., Liver transplantatior: Long lerm effectiveness. Report no. 92–07. Institute of Public Health, Rotterdam 1992.
EuroQol Group. EuroQol, a new facility for the measurernent of health related quality of life. Health Policv 1990; 16: 199–208.
Mannes GPM, De Boer WJ, Van der Bij W. Ervaringen met 300 patienten verwezen voor longtransplantatie. Ned Tijdschr Geneesk 1996; 140: 228–9.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
De Charro, F.T., De Wit, A. (1997). Costs of transplantation. In: Collins, G.M., Dubernard, J.M., Land, W., Persijn, G.G. (eds) Procurement, Preservation and Allocation of Vascularized Organs. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-5422-2_28
Download citation
DOI: https://doi.org/10.1007/978-94-011-5422-2_28
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-6280-0
Online ISBN: 978-94-011-5422-2
eBook Packages: Springer Book Archive